62.90
-0.7(-1.10%)
Currency In CHF
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
2207
First IPO Date
December 03, 2015
| Name | Title | Pay | Year Born |
| Mr. Thomas Meier | Chief Executive Officer, Chief Operating Officer & Chairman of Group Executive Board | 587,000 | 1968 |
| Dr. Gunther Loidl | Chief Technology Officer | 0 | 1970 |
| Mr. Alain Schaffter | Chief Financial Officer | 0 | 1977 |
| Dr. Daniel Grotzky | Head of Group Communications | 0 | N/A |
| Dr. Torsten Wohr | Chief Commercial Officer | 0 | 1968 |
| Dr. Anne-Kathrin Stoller Ph.D. | Chief Operating Officer of Bachem Americas, Inc. | 0 | 1974 |
| Mr. Michael Suter | Vice President of Global Accounting | 0 | N/A |
| Viviane Minden | Chief Human Resources Officer | 0 | N/A |
| Mr. Boris Corpataux | Vice President & Head Global Strategic Alliances | 0 | N/A |
| Mr. Achim Pluckebaum | Chief Information Officer | 0 | N/A |
Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.